3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 2
2
Phase 3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
2
Myelodysplastic Syndromes
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia
1
Interventions
Methotrexate
11
Busulfan
11
Cytarabine
10
fludarabine
8
Daunorubicin
8
Cyclophosphamide
8
fludarabine phosphate
7
Whole-Body Irradiation
7
Etoposide
7
Tacrolimus
6
Mitoxantrone
5
Melphalan
5
Idarubicin
5
Thioguanine
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Azacitidine
4
thymoglobulin
3
Radiotherapy
3
Filgrastim
3
Early Intervention, Educational
3
Decitabine
3
Cyclosporine
3
Asparaginase
3
Antilymphocyte Serum
3
merphos
2
luspatercept
2
decitabine and cedazuridine drug combination
2
Tretinoin
2
Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Myelodysplastic Syndromes
×
pevonedistat
×
Clear all
NCT03268954
2025-10-29
PANTHER
Takeda
Phase 3
Completed
454 enrolled
41 charts